Revalidatie -En Sportmedisch Centrum Schoten (SRL)

Active
VAT

BE 0660.574.156

Commercial name

Motionlab

Address
Geuzenveldenstraat 12A
2900 Schoten
Established
29-07-2016
Principal activity
Outpatient rehabilitation activities

Crisis resilience of Revalidatie -En Sportmedisch Centrum Schoten

Which companies are best armed against current economic trends and the energy crisis?

Read more

Financial data of Revalidatie -En Sportmedisch Centrum Schoten

2022 Financial statements 2021 Financial statements 2020 Financial statements 2019 Financial statements
Profit/Loss €13,738
28%
€10,729
246%
-€7,371
-53%
-€4,825
Equity €40,941
51%
€27,203
65%
€16,474
5%
€15,625
Gross margin €34,837
-45%
€63,537
38%
€46,145
-4%
€47,966

Frequently asked questions

What is the VAT number of Revalidatie -En Sportmedisch Centrum Schoten?
The VAT number of Revalidatie -En Sportmedisch Centrum Schoten is BE0660574156.
When was Revalidatie -En Sportmedisch Centrum Schoten founded?
Revalidatie -En Sportmedisch Centrum Schoten was founded on 29-07-2016.
What is the address of Revalidatie -En Sportmedisch Centrum Schoten?
The current registered office of Revalidatie -En Sportmedisch Centrum Schoten is located at Geuzenveldenstraat 12A, 2900 Schoten.
When was the last time Revalidatie -En Sportmedisch Centrum Schoten filed their annual financial statements?
The most recent financial statements of Revalidatie -En Sportmedisch Centrum Schoten were filed on 19-10-2023. You can view them here.
How many employees does Revalidatie -En Sportmedisch Centrum Schoten have?
There are currently no employees working at Revalidatie -En Sportmedisch Centrum Schoten or no workforce information is available.
What is the annual turnover of Revalidatie -En Sportmedisch Centrum Schoten?
At the time of its most recent financial statements, Revalidatie -En Sportmedisch Centrum Schoten did not publish any turnover figures. Revalidatie -En Sportmedisch Centrum Schoten reported a gross margin of €34,837.08.
Address

  You have disabled Javascript on your computer. To use this website, please enable Javascript first.


More details